{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:33:07Z","timestamp":1792873987228,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["20008575"],"award-info":[{"award-number":["20008575"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF- 2020R1C1C1008347"],"award-info":[{"award-number":["NRF- 2020R1C1C1008347"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021M3E5E3083401"],"award-info":[{"award-number":["NRF-2021M3E5E3083401"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biopha.2024.116781","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T03:47:09Z","timestamp":1716781629000},"page":"116781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["H1N1 nanobody development and therapeutic efficacy verification in H1N1-challenged mice"],"prefix":"10.1016","volume":"176","author":[{"given":"Jaehyun","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunseo","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeseok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Beum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Pil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7953-0914","authenticated-orcid":false,"given":"Jong-Woo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjoo","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhee","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Hwa","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yong","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daesub","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-5240","authenticated-orcid":false,"given":"Woonsung","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.116781_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1408.001","article-title":"Biology of influenza a virus","volume":"1102","author":"Cheung","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.116781_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tim.2014.01.010","article-title":"Bat-derived influenza-like viruses H17N10 and H18N11","volume":"22","author":"Wu","year":"2014","journal-title":"Trends Microbiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116781_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","article-title":"Influenza virus assembly and budding","volume":"411","author":"Rossman","year":"2011","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.biopha.2024.116781_bib4","first-page":"42","article-title":"Antigenic shift and drift","volume":"78","author":"Balgopal","year":"2011","journal-title":"Sci. Teach."},{"issue":"5446","key":"10.1016\/j.biopha.2024.116781_bib5","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1126\/science.286.5446.1921","article-title":"Predicting the evolution of human influenza A","volume":"286","author":"Bush","year":"1999","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.biopha.2024.116781_bib6","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1073\/pnas.94.15.7712","article-title":"Long term trends in the evolution of H (3) HA1 human influenza type A","volume":"94","author":"Fitch","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.116781_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/pathogens5040066","article-title":"Reviewing the history of pandemic influenza: understanding patterns of emergence and transmission","volume":"5","author":"Saunders-Hastings","year":"2016","journal-title":"Pathogens"},{"issue":"5","key":"10.1016\/j.biopha.2024.116781_bib8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s12250-021-00401-y","article-title":"Antigenic drift of the hemagglutinin from an influenza A (H1N1) pdm09 clinical isolate increases its pathogenicity in vitro","volume":"36","author":"Xing","year":"2021","journal-title":"Virol. Sin."},{"issue":"10127","key":"10.1016\/j.biopha.2024.116781_bib9","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.116781_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejim.2019.12.022","article-title":"Predictors of mortality of influenza virus infections in a Swiss Hospital during four influenza seasons: role of quick sequential organ failure assessment","volume":"74","author":"Papadimitriou-Olivgeris","year":"2020","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.116781_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4049\/jimmunol.1801010","article-title":"Influenza pathogenesis: the effect of host factors on severity of disease","volume":"202","author":"Gounder","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.116781_bib12","unstructured":"World Health Organization. Influenza (Seasonal). 2018."},{"issue":"2","key":"10.1016\/j.biopha.2024.116781_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3201\/eid1702.101724","article-title":"Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States","volume":"17","author":"Graitcer","year":"2011","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2024.116781_bib14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3201\/eid1704.101429","article-title":"H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients","volume":"17","author":"Renaud","year":"2011","journal-title":"Emerg. Infect. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2024.116781_bib15","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1093\/cid\/ciz101","article-title":"Effect of early oseltamivir treatment on mortality in critically ill patients with different types of influenza: a multiseason cohort study","volume":"69","author":"Lytras","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2024.116781_bib16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-2600(17)30174-1","article-title":"Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study","volume":"5","author":"Beigel","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.biopha.2024.116781_bib17","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2024.116781_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00284-20","article-title":"Monoclonal antibody therapy protects pharmacologically immunosuppressed mice from lethal infection with influenza B virus","volume":"64","author":"Marathe","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.biopha.2024.116781_bib19","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","article-title":"Influenza and antiviral resistance: an overview","volume":"39","author":"Lampejo","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"45","key":"10.1016\/j.biopha.2024.116781_bib20","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1016\/j.vaccine.2016.08.057","article-title":"Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications","volume":"34","author":"Sparrow","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biopha.2024.116781_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri1837","article-title":"Potent antibody therapeutics by design","volume":"6","author":"Carter","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116781_bib22","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nbt1363","article-title":"The growth and potential of human antiviral monoclonal antibody therapeutics","volume":"25","author":"Marasco","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116781_bib23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"issue":"6518","key":"10.1016\/j.biopha.2024.116781_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/374168a0","article-title":"A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks","volume":"374","author":"Greenberg","year":"1995","journal-title":"nature"},{"issue":"6428","key":"10.1016\/j.biopha.2024.116781_bib25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"issue":"1-3","key":"10.1016\/j.biopha.2024.116781_bib26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.vetimm.2008.10.299","article-title":"Camelid immunoglobulins and nanobody technology","volume":"128","author":"Muyldermans","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116781_bib27","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.drudis.2016.04.003","article-title":"Nanobodies as therapeutics: big opportunities for small antibodies","volume":"21","author":"Steeland","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2024.116781_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2024.116781_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/AAC.01802-15","article-title":"Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection","volume":"60","author":"Detalle","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6523","key":"10.1016\/j.biopha.2024.116781_bib30","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.abe4747","article-title":"Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2","volume":"370","author":"Xiang","year":"2020","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.biopha.2024.116781_bib31","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3390\/v13112214","article-title":"Structural biology of nanobodies against the spike protein of SARS-CoV-2","volume":"13","author":"Tang","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.biopha.2024.116781_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The therapeutic potential of nanobodies","volume":"34","author":"Jov\u010devska","year":"2020","journal-title":"BioDrugs"},{"issue":"8","key":"10.1016\/j.biopha.2024.116781_bib33","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/infdis\/jiq168","article-title":"Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection","volume":"203","author":"Ibanez","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2024.116781_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.antiviral.2012.12.014","article-title":"Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2)","volume":"97","author":"Tillib","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2024.116781_bib35","article-title":"Generation and characterization of a nanobody against the avian influenza virus H7 subtype","author":"Huang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"6523","key":"10.1016\/j.biopha.2024.116781_bib36","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.abe3255","article-title":"An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike","volume":"370","author":"Schoof","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2024.116781_bib37","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1038\/s41467-020-18174-5","article-title":"An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction","volume":"11","author":"Hanke","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116781_bib38","unstructured":"Organization W.H. Manual for the laboratory diagnosis and virological surveillance of influenza: World Health Organization; 2011.."},{"key":"10.1016\/j.biopha.2024.116781_bib39","article-title":"Monoclonal antibody targeting neutralizing epitope on H5N1 influenza virus of clade 1 and 0 for specific H5 quantification","volume":"2013","author":"He","year":"2013","journal-title":"Influenza Res. Treat."},{"issue":"3","key":"10.1016\/j.biopha.2024.116781_bib40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nprot.2014.039","article-title":"A general protocol for the generation of Nanobodies for structural biology","volume":"9","author":"Pardon","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2024.116781_bib41","unstructured":"Vaccinated WSG. Key Facts About Seasonal Flu Vaccine. 2012.."},{"issue":"4","key":"10.1016\/j.biopha.2024.116781_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"Hultberg","year":"2011","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.biopha.2024.116781_bib43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.antiviral.2011.09.002","article-title":"Nanobodies\u00ae: new ammunition to battle viruses","volume":"92","author":"Vanlandschoot","year":"2011","journal-title":"Antivir. Res."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2025.118212","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:05:10Z","timestamp":1781651110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224006656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":43,"alternative-id":["S0753332224006656"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116781","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H1N1 nanobody development and therapeutic efficacy verification in H1N1-challenged mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116781"}}